What is H.C. Wainwright's price target for RAPT?

H.C. Wainwright's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $6, from its action on May 22, 2025.

What is H.C. Wainwright's rating on RAPT?

H.C. Wainwright rates RAPT Buy, a bullish rating, as of May 22, 2025.

When did H.C. Wainwright last change its view on RAPT?

On May 22, 2025, H.C. Wainwright resumes coverage at Buy, price target $6.

H.C. Wainwright RAPT price target and rating history

RAPT Therapeutics Inc. (RAPT) · Health Care

H.C. Wainwright rates RAPT Therapeutics Inc. (RAPT) Buy with a $6 price target, as of its latest action on May 22, 2025. It has published 4 rating actions on RAPT since June 2021, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $6
Median target, all firms: Too few
Actions on RAPT: 4

H.C. Wainwright price target on RAPT

H.C. Wainwright price target on RAPT, each point a stated target, June 2021 to May 2025.

Every H.C. Wainwright rating on RAPT

May 22, 2025
ResumeH.C. Wainwright resumes coverage at Buy, price target $6
Dec 26, 2024
UpgradeH.C. Wainwright upgrades to Buy from Neutral, price target $10
Feb 21, 2024
DowngradeH.C. Wainwright downgrades to Neutral from Buy
Jun 23, 2021
ReiterateH.C. Wainwright raises its price target to $56 from $29, keeps Buy

Questions about H.C. Wainwright and RAPT

What is H.C. Wainwright's price target for RAPT?: H.C. Wainwright's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $6, from its action on May 22, 2025.
What is H.C. Wainwright's rating on RAPT?: H.C. Wainwright rates RAPT Buy, a bullish rating, as of May 22, 2025.
When did H.C. Wainwright last change its view on RAPT?: On May 22, 2025, H.C. Wainwright resumes coverage at Buy, price target $6.

More RAPT rating histories

All H.C. Wainwright ratings RAPT news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.